Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol in osteoarthritis of the knee
NCT01709214Phase 2Completed
- Sponsor
- Tris Pharma
- Start
- Dec 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cebranopadol in osteoarthritis (OA), sponsored by Tris Pharma. Started Dec 2012; status: completed.
02
Drugs
cebranopadol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01709214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01709214.